Kaken Pharmaceutical Co Financial Overview
Kaken Pharmaceutical Co's market cap is currently ¥144.80B. The company's EPS TTM is ¥19.03; its P/E ratio is 210.85; and it has a dividend yield of 4.23%. Kaken Pharmaceutical Co is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is ¥24.79. See an overview of income statement, balance sheet, and cash flow financials.
